来源:药智网/费翔
“天下苦脱发久矣。”
尚没有一副铮铮铁骨,能经得住这个四两拨千斤的拷问:你敢直面秃头么?
据世卫组织统计,全世界约有16亿人因脱发而遭受折磨。截至2021年底,我国脱发人口约为2.67亿人,到2026年底,这一数字将进一步提高到...查看全文
药明在线2022-11-25 16:34
近日,Concert Pharmaceuticals公布了其研究性口服药物deuruxolitinib(CTP-543)在中度至重度斑秃成年患者中的3期临床试验中更新的数据。据新闻稿,deuruxolitinib对脱发最严重以及脱发持续时间较长的患者也有显著的改善。
斑秃是一种自身免疫性疾病,免疫系统攻击毛囊,导致头皮和身体上的毛...查看全文
狮子做趋势交易2022-10-11 14:56
年初时凑热闹买了$Venus Acquisition(VENA)$ ,赌博玩一下。今天收到券商信息,要开始要约收购,需要我做个选择,No action还是Acting in concert,具体信息哪里都查不到。看这个股票下每天有人发帖,请问一下,该做什么选择?No action是不是不参与SPAC了?Acting in concert是不是就是参与SPAC收...查看全文
药明在线2022-05-30 15:18
近日,Concert Pharmaceuticals(以下简称Concert)宣布,3期临床试验THRIVE-AA1获得积极顶线结果,该试验评估了其口服在研药物CTP-543在成人中度至重度斑秃患者中的疗效。根据新闻稿,在THRIVE-AA1研究中,CTP-543在8 mg和12 mg两种研究剂量下均达到让头皮毛发再生的主要终点和关键次要终点。早在...查看全文
DeepTech深科技2022-05-26 21:55
5 月 23 日,位于马萨诸塞州的临床阶段生物公司 Concert Pharmaceuticals(NASDAQ:CNCE,以下简称 “Concert”)宣布了其最新的 3 期临床试验 THRIVE-AA1(NCT04518995)阳性顶线结果,该试验评估了其口服药物 CTP-543 对于成人中度至重度斑秃的治疗结果。
据悉,Concert 共围绕 CTP-543 开...查看全文
医药魔方2022-05-25 20:25
5月23日,Concert Pharmaceuticals公司宣布,其口服JAK抑制剂CTP-543针对中重度斑秃成年患者的III期临床(THRIVE-AA1)达到了主要研究终点和关键次要终点。结果显示,与安慰剂相比,在治疗24周后,高剂量组(12mg)有41.5%的患者实现头皮毛发覆盖率至少80%。
THRIVE-AA1是一项随机双盲、安慰剂...查看全文
$Concer Pharmaceuticals(CNCE)$ 8-K - Current report Filed: 2016-04-14 AccNo: 0001367920-16-000022 Size: 64 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain OfficersItem 9.01: ...
$Concer Pharmaceuticals(CNCE)$ 美东时间 2016-04-12 15:40 Concert Pharmaceuticals Inc at Needham Healthcare Conference 网页链接
$Concer Pharmaceuticals(CNCE)$ 8-K - Current report Filed: 2016-03-23 AccNo: 0001367920-16-000019 Size: 63 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain OfficersItem 9.01: ...
$Concer Pharmaceuticals(CNCE)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2016-03-04 AccNo: 0001144204-16-086103 Size: 108 KB 网页链接
$Concer Pharmaceuticals(CNCE)$ S-8 - Securities to be offered to employees in employee benefit plans Filed: 2016-03-01 AccNo: 0001367920-16-000015 Size: 171 KB 网页链接
$Concer Pharmaceuticals(CNCE)$ 8-K - Current report Filed: 2016-03-01 AccNo: 0001367920-16-000012 Size: 161 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$Concer Pharmaceuticals(CNCE)$ 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] Filed: 2016-03-01 AccNo: 0001367920-16-000014 Size: 7 MB 网页链接
$Concer Pharmaceuticals(CNCE)$ 美东时间 2016-03-01 09:00 Before Open:CONCERT PHARMA Earning Release . Wall St EPS Est ($):-0.07. 网页链接
$Concer Pharmaceuticals(CNCE)$ SC 13G - Statement of acquisition of beneficial ownership by individuals Filed: 2016-02-16 AccNo: 0001072613-16-000679 Size: 313 KB 网页链接
$Concer Pharmaceuticals(CNCE)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2016-02-16 AccNo: 0000921895-16-003391 Size: 246 KB 网页链接